chitosan has been researched along with Osteogenic Sarcoma in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.78) | 18.2507 |
| 2000's | 13 (36.11) | 29.6817 |
| 2010's | 12 (33.33) | 24.3611 |
| 2020's | 10 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Abo-Zeid, MAM; Ekram, B; Kandil, H | 1 |
| Bai, L; He, M; Ren, Z; Xiao, W | 1 |
| Choe, W; Moqbel, SAA; Ri, J; Sim, I; Su, H; Yan, W | 1 |
| Boccaccini, AR; Ciraldo, FE; Cresswell, M; Gritsch, L; Jackson, PR; Lovell, C; Maqbool, M; Mouriño, V | 1 |
| Huang, Z; Liu, C; Lu, R; Lu, Y; Song, K; Sun, H; Wang, Q; Zhao, F; Zheng, C | 1 |
| Altomare, L; Boccaccini, AR; Bonetti, L; Bono, N; Campiglio, CE; Candiani, G; De Nardo, L; Draghi, L; Farè, S; Panno, E | 1 |
| Bose, S; Koski, C; Vu, AA | 1 |
| Borges, A; Mello, D; Sato, T; Valente, AJM; Vasconcellos, L | 1 |
| Cai, C; Chen, Y; Chen, Z; Li, H; Liu, H; Zhang, R; Zheng, B | 1 |
| Asemi, Z; Hallajzadeh, J; Maleki Dana, P; Mansournia, MA; Yousefi, B | 1 |
| Cheng, DD; Guo, H; Li, SJ; Pan, Z; Wei, XJ; Yang, QC | 1 |
| Li, S; Xiong, Y; Zhang, X | 1 |
| Chi, Y; Feng, S; Guo, C; Liu, J; Sun, K; Wu, Z; Yin, X | 2 |
| Guo, YP; Ke, QF; Wen, X; Xie, XT; Yang, F | 1 |
| Huang, LL; Li, D; Pang, JD; Sun, K; Wang, F; Wang, LT; Wang, R; Zhang, LM | 1 |
| Guo, Y; Ke, Q; Lu, J; Peng, X; Xie, X; Yang, F | 1 |
| Li, RY; Liu, Z; Qin, YG; Wang, CY; Wang, QY; Zhang, BY; Zhu, LY | 1 |
| Chen, FJ; Chen, JS; Cheng, XF; Feng, XL; Guan, HP; Liu, XW; Ni, B; Sun, JZ | 1 |
| Choong, PF; Dass, CR; Dunstan, DE; Larson, I; Ta, HT | 2 |
| Choong, PF; Dass, CR; Dunstan, DE; Friedhuber, AM; Tan, ML | 2 |
| Dass, CR; Friedhuber, AM; Tan, ML | 1 |
| Ni, M; Ratner, B; Zhang, M; Zhang, Y | 1 |
| Hayashi, Y; Ohara, N; Yamada, S | 1 |
| Hayashi, Y; Ikeda, T; Kim, SK; Matsunaga, T; Ohara, N; Yamada, S; Yanagiguchi, K | 1 |
| Fernandes, MH; Hayakawa, S; Lopes, MA; Osaka, A; Santos, JD; Shirosaki, Y; Tsuru, K | 1 |
| Ho, MH; Hou, LT; Hsieh, HJ; Hsien, TY; Lai, JY; Liu, HC; Wang, DM | 1 |
| Chang, YN; Hsieh, CY; Hsieh, HJ; Tsai, SP; Wang, DM | 1 |
| Kumary, TV; Ramesh, P; Sailaja, GS; Varma, HK | 1 |
| Choong, PF; Contreras, KG; Dass, CR; Dunstan, DE | 1 |
| Bumgardner, JD; Chesnutt, BM; Haggard, WO; Wright, L; Yuan, Y | 1 |
| Alves, CM; Coutinho, DF; Marques, AP; Neves, NM; Pashkuleva, IH; Reis, RL | 1 |
| Choong, PF; Dass, CR; Dunstan, DE; Friedhuber, AM; Khachigian, LM | 1 |
| Chen, A; Hou, C; Zhang, Y | 1 |
1 review(s) available for chitosan and Osteogenic Sarcoma
| Article | Year |
|---|---|
Chitosan applications in studying and managing osteosarcoma.
Topics: Biocompatible Materials; Bone Neoplasms; Chitin; Chitosan; Drug Delivery Systems; Humans; Osteosarcoma; Tissue Engineering | 2021 |
35 other study(ies) available for chitosan and Osteogenic Sarcoma
| Article | Year |
|---|---|
Cytocompatibility of MG-63 osteosarcoma cells on chitosan/hydroxyapatite/lignin hybrid composite scaffold
Topics: Biocompatible Materials; Chitosan; Durapatite; Humans; Lignin; Osteosarcoma; Tissue Engineering; Tissue Scaffolds | 2022 |
Chitosan targets PI3K/Akt/FoxO3a axis to up-regulate FAM172A and suppress MAPK/ERK pathway to exert anti-tumor effect in osteosarcoma.
Topics: Bone Neoplasms; Cell Line, Tumor; Chitosan; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proteins; Proto-Oncogene Proteins c-akt | 2023 |
Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Chitosan; Humans; Oligosaccharides; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2023 |
Chitosan/hydroxyapatite composite bone tissue engineering scaffolds with dual and decoupled therapeutic ion delivery: copper and strontium.
Topics: Biocompatible Materials; Bone Neoplasms; Bone Regeneration; Cell Differentiation; Chitosan; Copper; Durapatite; Humans; Osteoblasts; Osteogenesis; Osteosarcoma; Strontium; Tissue Engineering; Tumor Cells, Cultured | 2019 |
Strontium/Chitosan/Hydroxyapatite/Norcantharidin Composite That Inhibits Osteosarcoma and Promotes Osteogenesis In Vitro.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Bone Development; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Chitosan; Freeze Drying; Humans; Hydroxyapatites; Microscopy, Electron, Scanning; Nanoparticles; Necrosis; Osteoblasts; Osteogenesis; Osteosarcoma; Particle Size; Sincalide; Spectroscopy, Fourier Transform Infrared; Strontium; X-Ray Diffraction | 2020 |
Electrophoretic processing of chitosan based composite scaffolds with Nb-doped bioactive glass for bone tissue regeneration.
Topics: Biocompatible Materials; Bone Regeneration; Cell Line, Tumor; Ceramics; Chitosan; Electrophoresis; Gelatin; Glass; Humans; Hydrogen-Ion Concentration; Materials Testing; Microscopy, Electron, Scanning; Niobium; Osteosarcoma; Spectroscopy, Fourier Transform Infrared; Tissue Scaffolds | 2020 |
Effects of chitosan-loaded hydroxyapatite on osteoblasts and osteosarcoma for chemopreventative applications.
Topics: Biocompatible Materials; Bone Neoplasms; Bone Regeneration; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chitosan; Delayed-Action Preparations; Durapatite; Humans; Osteoblasts; Osteosarcoma; Tissue Scaffolds | 2020 |
Chitosan-Based Coacervate Polymers for Propolis Encapsulation: Release and Cytotoxicity Studies.
Topics: Anti-Infective Agents; Apoptosis; Bone Neoplasms; Cell Proliferation; Chitosan; Drug Delivery Systems; Humans; Hydrogels; Osteosarcoma; Polymers; Propolis; Tumor Cells, Cultured | 2020 |
A Biocompatible, Stimuli-Responsive, and Injectable Hydrogel with Triple Dynamic Bonds.
Topics: Alginates; Biocompatible Materials; Bone Neoplasms; Cell Proliferation; Chitosan; Humans; Hydrogels; Osteosarcoma; Polymers; Polysaccharides; Tissue Engineering; Tumor Cells, Cultured | 2020 |
Chitooligosaccharides inhibit tumor progression and induce autophagy through the activation of the p53/mTOR pathway in osteosarcoma.
Topics: Animals; Apoptosis; Autophagy; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chitin; Chitosan; Cisplatin; Disease Progression; Female; Humans; Hydrolysis; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Oligosaccharides; Osteosarcoma; Polymers; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2021 |
Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Humans; Methotrexate; Nanoparticles; Osteosarcoma; Poloxamer | 2017 |
Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Chitin; Chitosan; Cholesterol; Cytoplasm; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Humans; Liposomes; Male; Mice; Mice, Nude; Oligosaccharides; Osteosarcoma; Particle Size; Rats; Rats, Sprague-Dawley; Surface Properties | 2017 |
pH-responsive mesoporous ZSM-5 zeolites/chitosan core-shell nanodisks loaded with doxorubicin against osteosarcoma.
Topics: Adult; Animals; Biomarkers; Cell Death; Cell Line, Tumor; Chitosan; Doxorubicin; Humans; Hydrogen-Ion Concentration; L-Lactate Dehydrogenase; Male; Malondialdehyde; Mesenchymal Stem Cells; Models, Biological; Nanoparticles; Nitrogen; Osteosarcoma; Porosity; Rats, Sprague-Dawley; Temperature; Tissue Distribution; X-Ray Diffraction; Zeolites | 2018 |
Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy.
Topics: Animals; Bone Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Chitosan; Dendrimers; Folic Acid; Gene Silencing; Genetic Therapy; Humans; Male; Matrix Metalloproteinase 2; Membrane Proteins; Mice, Nude; Nanoparticles; Osteosarcoma; Polylysine; RNA-Binding Proteins; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2018 |
Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
Topics: Animals; Antibiotics, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Chitin; Chitosan; Cholesterol; Doxorubicin; Drug Compounding; Drug Liberation; Estrone; Glutathione; Humans; Injections, Intravenous; Liposomes; Male; Mice, Inbred BALB C; Mice, Nude; Oligosaccharides; Osteosarcoma; Particle Size; Polyethylene Glycols; Receptors, Estrogen; Technology, Pharmaceutical; Time Factors; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Magnetic Mesoporous Calcium Sillicate/Chitosan Porous Scaffolds for Enhanced Bone Regeneration and Photothermal-Chemotherapy of Osteosarcoma.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Neoplasms; Bone Regeneration; Calcium Compounds; Calcium, Dietary; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chitosan; Doxorubicin; Drug Delivery Systems; Ferric Compounds; Humans; Hyperthermia, Induced; Mesenchymal Stem Cells; Mice; Mice, Nude; Osteogenesis; Osteosarcoma; Porosity; Silicates; Tissue Engineering; Tissue Scaffolds; Xenograft Model Antitumor Assays | 2018 |
Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Cyclohexanones; Enhancer of Zeste Homolog 2 Protein; Humans; Male; Mice; Mitochondria; Nanoparticles; Neoplasm Invasiveness; Neoplasm Metastasis; Osteosarcoma; Phosphorylation; Polycomb Repressive Complex 2; Proto-Oncogene Proteins c-akt; Time Factors; Transfection; Tretinoin | 2015 |
Effects of RNA interference-mediated knockdown of livin and survivin using monomethoxypolyethylene glycol-chitosan nanoparticles in MG-63 osteosarcoma cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Shape; Chitosan; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Inhibitor of Apoptosis Proteins; Nanoparticles; Neoplasm Proteins; Osteosarcoma; Polyethylene Glycols; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Survivin | 2016 |
A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Doxorubicin; Drug Carriers; Female; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Xenograft Model Antitumor Assays | 2009 |
A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy.
Topics: Animals; Biological Assay; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Delivery Systems; Eye Proteins; Genetic Therapy; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Lung Neoplasms; Mice; Microscopy, Fluorescence; Nerve Growth Factors; Osteosarcoma; Phosphates; Rheology; Serpins; Solutions | 2009 |
The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model.
Topics: Adolescent; Animals; Antibiotics, Antineoplastic; Biocompatible Materials; Cell Line; Child; Chitosan; Dextran Sulfate; Doxorubicin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Humans; Male; Materials Testing; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Weight; Neoplasm Transplantation; Osteosarcoma | 2010 |
A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site.
Topics: Animals; Bone Neoplasms; Chitosan; DNA; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Osteosarcoma | 2010 |
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Disease Progression; DNA, Catalytic; Doxorubicin; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Stability; Drugs, Investigational; Humans; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Osteosarcoma; Xenograft Model Antitumor Assays | 2013 |
Calcium phosphate-chitosan composite scaffolds for bone tissue engineering.
Topics: Alkaline Phosphatase; Biocompatible Materials; Biodegradation, Environmental; Biomarkers; Bone Neoplasms; Bone Substitutes; Cell Culture Techniques; Cell Differentiation; Cell Division; Chitin; Chitosan; Durapatite; Glass; Humans; Isoenzymes; Materials Testing; Microscopy, Electron, Scanning; Neoplasm Proteins; Osteoblasts; Osteocalcin; Osteosarcoma; Solubility; Tissue Engineering; Tumor Cells, Cultured | 2003 |
Mineralization of matrix vesicles isolated from a human osteosarcoma cell line in culture with water-soluble chitosan-containing medium.
Topics: Alkaline Phosphatase; Base Sequence; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcification, Physiologic; Cell Line, Tumor; Chitin; Chitosan; Culture Media; DNA Primers; Humans; Osteosarcoma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Solubility; Transforming Growth Factor beta; Water | 2003 |
Early gene expression analyzed by cDNA microarray and RT-PCR in osteoblasts cultured with water-soluble and low molecular chitooligosaccharide.
Topics: Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; CD56 Antigen; Cell Culture Techniques; Cell Differentiation; Cell Division; Cell Line, Tumor; Chitin; Chitosan; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Molecular Weight; Oligonucleotide Array Sequence Analysis; Osteoblasts; Osteogenesis; Osteosarcoma; Reverse Transcriptase Polymerase Chain Reaction; Solubility; Tissue Plasminogen Activator; Transforming Growth Factor beta; Water | 2004 |
In vitro cytocompatibility of MG63 cells on chitosan-organosiloxane hybrid membranes.
Topics: Alkaline Phosphatase; Biocompatible Materials; Bone Neoplasms; Calcium; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line, Tumor; Chitosan; Cross-Linking Reagents; Humans; Magnetic Resonance Spectroscopy; Materials Testing; Membranes, Artificial; Microscopy, Electron, Scanning; Neoplasm Proteins; Osteoblasts; Osteosarcoma; Silanes; Spectroscopy, Fourier Transform Infrared; Wettability | 2005 |
Preparation and characterization of RGD-immobilized chitosan scaffolds.
Topics: Amino Acids; Animals; Biocompatible Materials; Bone and Bones; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chitin; Chitosan; Culture Techniques; Immunohistochemistry; Microscopy, Electron, Scanning; Oligopeptides; Osteoblasts; Osteosarcoma; Peptides; Rats; Spectrophotometry, Infrared; Spectroscopy, Fourier Transform Infrared; Time Factors; Tissue Engineering | 2005 |
Preparation of gamma-PGA/chitosan composite tissue engineering matrices.
Topics: Absorbable Implants; Adsorption; Animals; Biocompatible Materials; Cell Culture Techniques; Cell Line, Tumor; Cell Size; Cell Survival; Chitosan; Elasticity; Extracellular Matrix; Manufactured Materials; Materials Testing; Molecular Conformation; Osteosarcoma; Polyglutamic Acid; Porosity; Protein Binding; Rats; Serum Albumin, Bovine; Surface Properties; Tensile Strength; Tissue Engineering; Water | 2005 |
Human osteosarcoma cell adhesion behaviour on hydroxyapatite integrated chitosan-poly(acrylic acid) polyelectrolyte complex.
Topics: Acrylic Resins; Biocompatible Materials; Cell Adhesion; Cell Culture Techniques; Cell Line; Chitosan; Durapatite; Electrolytes; Humans; Materials Testing; Osteosarcoma; Tissue Engineering | 2006 |
Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.
Topics: Angiogenesis Inhibitors; Animals; Bone Neoplasms; Cell Line, Tumor; Chitosan; Drug Compounding; Eye Proteins; Female; Genes, Reporter; Green Fluorescent Proteins; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Nerve Growth Factors; Osteosarcoma; Particle Size; Plasmids; Serpins; Transfection | 2007 |
Mechanical property, degradation rate, and bone cell growth of chitosan coated titanium influenced by degree of deacetylation of chitosan.
Topics: Bone and Bones; Cell Culture Techniques; Chitosan; Coated Materials, Biocompatible; Humans; Implants, Experimental; Materials Testing; Muramidase; Orthopedics; Osteosarcoma; Polymers; Stress, Mechanical; Surface Properties; Tensile Strength; Titanium | 2008 |
The effect of chitosan on the in vitro biological performance of chitosan-poly(butylene succinate) blends.
Topics: Biocompatible Materials; Butylene Glycols; Cell Adhesion; Cell Proliferation; Chitosan; Fibronectins; Humans; In Vitro Techniques; Models, Chemical; Osteosarcoma; Polymers; Serum Albumin; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tumor Cells, Cultured | 2008 |
Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity.
Topics: Animals; Apoptosis; Biocompatible Materials; Biotechnology; Bone and Bones; Chitosan; DNA, Catalytic; Drug Delivery Systems; Mice; Mice, Inbred BALB C; Nanoparticles; Nanotechnology; Osteosarcoma; Placebos; Proto-Oncogene Proteins c-jun | 2008 |
[In vitro experimental study of adriamycin-loaded chitosan drug delivery system].
Topics: Antibiotics, Antineoplastic; Bone Neoplasms; Chitin; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Osteosarcoma; Random Allocation; Tumor Cells, Cultured | 1997 |